Doseology Sciences Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DOSEF research report →
About the company
Doseology Sciences Inc. is a Canadian firm dedicated to the cultivation and extraction of ingredients for both nutraceutical and pharmaceutical applications. The company's primary focus lies in the research, development, and commercialization of medicinal mushroom products, offered in various forms such as tinctures and powders.
- CEO
- Christopher Jackson
- IPO
- 2022
- Employees
- 3
- HQ
- Kelowna, BC, CA
Price Chart
- Market Cap
- $504.51K
- P/E
- -1.25
- P/S
- 10.25
- P/B
- 2.05
- EV/EBITDA
- -0.39
- Div Yield
- 0.00%
- Gross Margin
- -517.35%
- Op Margin
- -1462.99%
- Net Margin
- -1439.30%
- ROE
- -85.01%
- ROIC
- -107.98%
- Revenue
- $31.26K · -68.27%
- Net Income
- $-328,900 · 3.22%
- EPS
- $-0.07 · 10.75%
- Op Income
- $-346,394
- FCF YoY
- -45.56%
- 52W High
- $1.50
- 52W Low
- $0.01
- 50D MA
- $0.26
- 200D MA
- $0.52
- Beta
- 2.23
- Avg Volume
- 559
Get TickerSpark's AI analysis on DOSEF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our DOSEF coverage
Recent articles, reports, and earnings notes.
No research on DOSEF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DOSEF report →Similar companies
Peers in the same neighborhood.